Rheumatology

For USA healthcare professionals only. This article highlights the increased infection risks associated with immunocompromised rheumatological patients presented at ACR 2023.

The chronic inflammatory diseases axial spondyloarthritis (AxS) and psoriatic arthritis (PsA) involve symptoms such as axial skeleton pain…

AAV is a rare and severe multisystem disease affecting the small arteries.1,2 The condition is characterised by systemic inflammation across multiple body sites including the lungs, joints, kidneys, nerves, ears, and nose.1,2 Glucocorticoids and immunosuppressants form the cornerstone of current treatment approaches.

Psoriatic arthritis (PsA) is a chronic, heterogeneous, immune-mediated arthritis characterised by joint inflammation and…

This Janssen-sponsored live symposium entitled “The Launching Pad: Exploring the Potential of the IL-23 Pathway in PsA…

Rheumatoid arthritis (RA) is a chronic, progressive, inflammatory joint disease characterised by symmetrical inflammation of the peripheral…

This symposium was developed to consider the future role that AI might play in the management of rheumatic diseases. First, Ignacio Medrano considered the current use of AI in healthcare and its possible future applications.

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an umbrella term for a group of rare, multisystem autoimmune…